📰 Platform Technology News
Page 28 - Platform Technology News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Platform Technology. Real-time updates on events, politics, business and more.
January 12, 2022
/PRNewswire/ -- TradeStation Group, Inc. ("TradeStation"), a Monex Group company and an award-winning*, self-clearing online brokerage for trading stocks,...
January 5, 2022
Read the latest Insulin headlines, on NewsNow: the one-stop shop for Insulin news
December 17, 2021
PRINCETON, NJ / ACCESSWIRE / December 17, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs
December 17, 2021
Sonnet BioTherapeutics Provides Fiscal Year 2021 Business and Financial Update PRINCETON, NJ / ACCESSWIRE / December 17, 2021 / Sonnet BioTherapeutics Holdings, Inc. , a... | December 17, 2021
December 1, 2021
Paul Toon joins Smart as plans for US-based and international M&A activity ramps upNASHVILLE, TN / ACCESSWIRE / December 1, 2021 / Smart, a leading global retirement technology provider, announced that
November 30, 2021
/PRNewswire/ -- Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug...
November 30, 2021
/PRNewswire/ -- Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug...
October 28, 2021
/PRNewswire/ -- Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug...
October 13, 2021
/PRNewswire/ -- Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug...
September 29, 2021
- Partner Shanghai Miracogen (fully owned by LEPU BIOPHARMA CO., LTD) commences US Phase I/II trial with ADC designed to treat solid tumors - MRG004A selected for clinical development based